| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.43B | 55.82B | 56.40B | 52.04B | 45.79B | 47.07B |
| Gross Profit | 9.73B | 8.89B | 9.80B | 9.72B | 7.09B | 8.31B |
| EBITDA | 4.25B | 3.63B | 4.67B | 5.17B | 2.79B | 4.33B |
| Net Income | 781.00M | 655.00M | 1.10B | 1.96B | 348.00M | 1.68B |
Balance Sheet | ||||||
| Total Assets | 56.39B | 57.46B | 60.50B | 61.84B | 53.58B | 54.92B |
| Cash, Cash Equivalents and Short-Term Investments | 10.73B | 8.14B | 11.13B | 14.77B | 10.71B | 10.58B |
| Total Debt | 569.00M | 983.00M | 595.00M | 358.00M | 456.00M | 544.00M |
| Total Liabilities | 19.57B | 19.82B | 23.09B | 24.27B | 19.05B | 20.24B |
| Stockholders Equity | 35.69B | 36.57B | 36.23B | 36.33B | 33.49B | 33.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.11B | -2.44B | 4.52B | 248.00M | 476.00M |
| Operating Cash Flow | 0.00 | 799.00M | 1.33B | 7.11B | 2.96B | 2.97B |
| Investing Cash Flow | 0.00 | -3.23B | -4.49B | -1.92B | -1.94B | -2.75B |
| Financing Cash Flow | 0.00 | -661.00M | -1.29B | -587.00M | -703.00M | -1.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥45.18B | 8.51 | ― | 3.53% | -7.83% | 13.79% | |
74 Outperform | ¥132.47B | 49.21 | ― | 0.67% | 8.51% | -17.90% | |
73 Outperform | ¥187.27B | 13.86 | 4.41% | 3.80% | -4.32% | 27.07% | |
67 Neutral | ¥103.06B | 13.18 | ― | 3.88% | -8.00% | -7.64% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | ¥17.53B | 7.86 | ― | 1.39% | 3.43% | 490.61% | |
55 Neutral | ¥21.58B | 32.05 | ― | 4.09% | -1.03% | -40.31% |